[Treatment of bronchial asthma with consideration also of the upper airway].
Asthma is chronic inflammatory disease of the lower airway. In many cases, it is accompanied by allergic or non-allergic upper airway disease. While the treatment of the lower airway in bronchial asthma has been largely standardized based on diverse guidelines, for the simultaneous treatment of the upper airway, different strategies are in use. On the basis of collected study data, it has been shown that simultaneous pharmacotherapy of the upper airway comorbidities also has a positive effect on asthma. It has been shown that, when applied in good time, specific immunotherapy can prevent the development of asthma in some cases. This means that in patients with airway pathology, simultaneous treatment of the other level (upper or lower) should be considered.
Schultze-Werninghaus
G
G
Berufsgenossenschaftliche Kliniken Bergmannsheil, Universitätsklinik Medizinische Klinik III, Bochum. Gerhard.Schultze-Werninghaus@ruhr-uni-bochum.de
D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D001249:Asthma / Q000276:immunology / Q000628:therapy*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D008176:Lung Volume Measurements; D012221:Rhinitis, Allergic, Perennial / Q000276:immunology / Q000628:therapy*; D006255:Rhinitis, Allergic, Seasonal / Q000276:immunology / Q000628:therapy*
D018926:Anti-Allergic Agents; D005938:Glucocorticoids